NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,264 | -84.3% | 57,528 | -84.8% | 0.00% | -100.0% |
| Q2 2023 | $217,655 | +77.0% | 378,398 | +595.3% | 0.00% | 0.0% |
| Q4 2022 | $122,989 | -27.2% | 54,420 | +22.4% | 0.00% | 0.0% |
| Q2 2022 | $169,000 | -72.2% | 44,471 | +57.9% | 0.00% | -94.7% |
| Q4 2019 | $608,000 | +85.4% | 28,157 | +205.9% | 0.02% | -75.6% |
| Q2 2019 | $328,000 | +60.0% | 9,205 | +47.6% | 0.08% | -11.4% |
| Q4 2018 | $205,000 | -50.0% | 6,237 | -7.3% | 0.09% | +60.0% |
| Q3 2018 | $410,000 | – | 6,726 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
| GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
| Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
| Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
| MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
| Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
| Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
| CM Management, LLC | 50,000 | $898,000 | 0.67% |
| Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |